Human ApoE4 PharmaGenie ELISA Kit (SBRS0277)

Apolipoprotein E4 isoform quantification underpins Alzheimer's disease research, cardiovascular investigations, and pharmacogenomic screening efforts, where this protein variant serves as a major genetic risk marker for late-onset dementia. The Assay Genie human ApoE4 immunoassay kit provides isoform-specific measurement capabilities for laboratories studying lipid metabolism, neurodegeneration, and therapeutic response.

Validated for compatibility with cell culture supernatant, plasma and serum specimens in research workflows, the kit accommodates diverse experimental designs from clinical cohort studies to in vitro cellular models. Each microplate kit includes reagents sufficient for 96 individual determinations, supporting medium-throughput experimental protocols with absorbance-based measurement on standard laboratory plate readers.

Researchers investigating genotype-phenotype correlations in neurological disease benefit from isoform-specific targeting, distinguishing ApoE4 from ApoE2 and ApoE3 variants. Application areas include dementia epidemiology, lipid transport mechanism studies, and drug development pipelines targeting apolipoprotein pathways. Store at 4°C to preserve reagent activity throughout the workflow. For research use only applications.